These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 15242421

  • 1. Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients.
    Wada-Isoe K, Wakutani Y, Urakami K, Nakashima K.
    Acta Neurol Scand; 2004 Aug; 110(2):124-7. PubMed ID: 15242421
    [Abstract] [Full Text] [Related]

  • 2. Cerebrospinal fluid tau, Abeta1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia.
    Jia JP, Meng R, Sun YX, Sun WJ, Ji XM, Jia LF.
    Neurosci Lett; 2004 Aug; 383(1-2):12-6. PubMed ID: 15936505
    [Abstract] [Full Text] [Related]

  • 3. Total tau in cerebrospinal fluid differentiates Alzheimer's disease from vascular dementia.
    Leszek J, Małyszczak K, Janicka B, Kiejna A, Wiak A.
    Med Sci Monit; 2003 Nov; 9(11):CR484-8. PubMed ID: 14586274
    [Abstract] [Full Text] [Related]

  • 4. [Diagnostic value of tau in cerebrospinal fluid in alzheimer disease].
    Hu Y, He S, Wang J.
    Zhonghua Yi Xue Za Zhi; 2001 Nov 25; 81(22):1377-9. PubMed ID: 11930632
    [Abstract] [Full Text] [Related]

  • 5. Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.
    Hampel H, Buerger K, Zinkowski R, Teipel SJ, Goernitz A, Andreasen N, Sjoegren M, DeBernardis J, Kerkman D, Ishiguro K, Ohno H, Vanmechelen E, Vanderstichele H, McCulloch C, Moller HJ, Davies P, Blennow K.
    Arch Gen Psychiatry; 2004 Jan 25; 61(1):95-102. PubMed ID: 14706948
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-12 is reduced in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
    Rentzos M, Paraskevas GP, Kapaki E, Nikolaou C, Zoga M, Rombos A, Tsoutsou A, Vassilopoulos D D.
    J Neurol Sci; 2006 Nov 15; 249(2):110-4. PubMed ID: 16843497
    [Abstract] [Full Text] [Related]

  • 7. [Cerebrospinal fluid protein tau levels in the differential diagnosis of Alzheimer's disease].
    Schonknecht P, Pantel J, Werle E, Hartmann T, Essig M, Baudendistel K, Beyreuther K, Schroder J.
    Fortschr Neurol Psychiatr; 2000 Oct 15; 68(10):439-46. PubMed ID: 11103680
    [Abstract] [Full Text] [Related]

  • 8. Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia.
    Jia JP, Jia JM, Zhou WD, Xu M, Chu CB, Yan X, Sun YX.
    Chin Med J (Engl); 2004 Aug 15; 117(8):1161-4. PubMed ID: 15361288
    [Abstract] [Full Text] [Related]

  • 9. Basic and clinical studies on the measurement of tau protein in cerebrospinal fluid as a biological marker for Alzheimer's disease and related disorders: multicenter study in Japan.
    Nishimura T, Takeda M, Nakamura Y, Yosbida Y, Arai H, Sasaki H, Shouji M, Hirai S, Khise K, Tanaka K, Hamamoto M, Yamamoto H, Matsubayashi T, Urakami K, Adachi Y, Nakashima K, Toji H, Nakamura S, Yoshida H.
    Methods Find Exp Clin Pharmacol; 1998 Apr 15; 20(3):227-35. PubMed ID: 9646285
    [Abstract] [Full Text] [Related]

  • 10. Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: marker candidates for dementia with Lewy bodies.
    Mollenhauer B, Steinacker P, Bahn E, Bibl M, Brechlin P, Schlossmacher MG, Locascio JJ, Wiltfang J, Kretzschmar HA, Poser S, Trenkwalder C, Otto M.
    Neurodegener Dis; 2007 Apr 15; 4(5):366-75. PubMed ID: 17622779
    [Abstract] [Full Text] [Related]

  • 11. Cerebrospinal fluid markers in differential diagnosis of Alzheimer's disease and vascular dementia.
    Boban M, Grbić K, Mladinov M, Hof PR, Süssmair C, Ackl N, Stanić G, Bader B, Danek A, Simić G.
    Coll Antropol; 2008 Jan 15; 32 Suppl 1():31-6. PubMed ID: 18405055
    [Abstract] [Full Text] [Related]

  • 12. Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases.
    Brettschneider J, Widl K, Ehrenreich H, Riepe M, Tumani H.
    Neurosci Lett; 2006 Sep 01; 404(3):347-51. PubMed ID: 16815630
    [Abstract] [Full Text] [Related]

  • 13. Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia.
    Di Rosa M, Dell'Ombra N, Zambito AM, Malaguarnera M, Nicoletti F, Malaguarnera L.
    Eur J Neurosci; 2006 May 01; 23(10):2648-56. PubMed ID: 16817867
    [Abstract] [Full Text] [Related]

  • 14. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
    Smach MA, Charfeddine B, Lammouchi T, Harrabi I, Ben Othman L, Dridi H, Bennamou S, Limem K.
    Neurosci Lett; 2008 Aug 01; 440(2):145-9. PubMed ID: 18555606
    [Abstract] [Full Text] [Related]

  • 15. Blood-based neurochemical diagnosis of vascular dementia: a pilot study.
    Bibl M, Esselmann H, Mollenhauer B, Weniger G, Welge V, Liess M, Lewczuk P, Otto M, Schulz JB, Trenkwalder C, Kornhuber J, Wiltfang J.
    J Neurochem; 2007 Oct 01; 103(2):467-74. PubMed ID: 17662050
    [Abstract] [Full Text] [Related]

  • 16. Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia.
    Zuliani G, Ranzini M, Guerra G, Rossi L, Munari MR, Zurlo A, Volpato S, Atti AR, Blè A, Fellin R.
    J Psychiatr Res; 2007 Oct 01; 41(8):686-93. PubMed ID: 16600299
    [Abstract] [Full Text] [Related]

  • 17. Neuropsychological and behavioural correlates of CSF biomarkers in dementia.
    Engelborghs S, Maertens K, Vloeberghs E, Aerts T, Somers N, Mariën P, De Deyn PP.
    Neurochem Int; 2006 Mar 01; 48(4):286-95. PubMed ID: 16434124
    [Abstract] [Full Text] [Related]

  • 18. Cytokine profiles and the role of cellular prion protein in patients with vascular dementia and vascular encephalopathy.
    Schmitz M, Hermann P, Oikonomou P, Stoeck K, Ebert E, Poliakova T, Schmidt C, Llorens F, Zafar S, Zerr I.
    Neurobiol Aging; 2015 Sep 01; 36(9):2597-606. PubMed ID: 26170132
    [Abstract] [Full Text] [Related]

  • 19. Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease.
    Popp J, Bacher M, Kölsch H, Noelker C, Deuster O, Dodel R, Jessen F.
    J Psychiatr Res; 2009 May 01; 43(8):749-53. PubMed ID: 19038405
    [Abstract] [Full Text] [Related]

  • 20. Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients.
    Rota E, Bellone G, Rocca P, Bergamasco B, Emanuelli G, Ferrero P.
    Neurol Sci; 2006 Apr 01; 27(1):33-9. PubMed ID: 16688597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.